King Charles III’s Surgery; COVID Timeline Doubted; FDA Approvals Hit High
Note that some links may require registration or subscription. Britain’s King Charles III is scheduled for surgery for an enlarged prostate, and Buckingham Palace stressed that it is a benign condition. (BBC News) FDA announced that Emergent BioSolutions, the manufacturer of naloxone (Narcan), will extend the 4 mg nasal spray’s shelf life from 3 to […]